Consultant and Professor Peter Jepsen is a new Doctor of Medical Science (DMSc) at Aarhus University and Aarhus University Hospital. Here, he conducts research into the prognosis for patients with cirrhosis of the liver and, among other things, examines the risk of liver cancer for patients with alcohol-related cirrhosis.
2021.06.29 |
Peter Jepsen is an expert in clinical epidemiology within liver diseases. He utilises epidemiological methods and Danish registry data to study liver diseases and their incidence, so that he can identify people with a particularly high or low risk of developing the disease. And then he develops methods to predict the course of the disease in patients who suffer a liver disease.
In his higher doctoral dissertation, Peter Jepsen is particularly concerned with the extent to which patients with alcohol-related cirrhosis have a greater risk of developing liver cancer. His studies show that the risk is far higher than the risk for people without cirrhosis of the liver, but in absolute terms, the risk is still low. This knowledge is important for decisions on screening for liver cancer among patients with cirrhosis of the liver.
In the dissertation, Peter Jepsen also examines what selected prescription drugs mean for cirrhosis patients' prognosis, while also looking into whether this has consequences for patient survival if they also suffer from comorbid diseases.
Professor, Consultant, DMSc Peter Jepsen
Aarhus University, Department of Clinical Medicine and
Aarhus University Hospital, Department of Hepatology and Gastroenterology
Mobile: (+45) 29 31 44 66
Email: pj@clin.au.dk